Ȩ > Publication > ±¹ Á¦

ÀÛ¼ºÀÚ :      ÀÛ¼ºÀÏ :     2009-02-26 (13:51:38)
À̸ÞÀÏ :      Á¶È¸¼ö :     39085
ȨÆäÀÌÁö :      ¾ÆÀÌÇÇ :     ***.***.***.***
±ÛÁ¦¸ñ :     Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter.
 
Biochem Biophys Res Commun. 2003 Jun 20;306(1):239-43

Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter.

Kidney Institute, Keimyung University School of Medicine, 700-712, Daegu, Republic of Korea.

The dihydrofolate reductase (dhfr) promoter contains cis-acting elements for Sp1 and E2F. Here we examined the cooperative regulation of dhfr gene transcription by Sp1 and E2F in human osteosarcoma cells, U2OS. Trichostatin A, an inhibitor of histone deacetylases, markedly stimulated dhfr promoter activity, a response that was enhanced by the deletion of an E2F element. In contrast, deletion of the dhfr Sp1 binding sites completely abolished promoter stimulation by trichostatin A. Cotransfection assays showed that activation of dhfr transcription by expression of E2F1/DP1 requires the reiterated Sp1 elements, whereas activation by Sp1 was enhanced by the deletion of the E2F element. Expression of HDAC1 with Sp1 suppressed promoter activity and suppression was not alleviated by coexpression of E2F1/DP1. These results suggest that HDAC1 acts through Sp1 to repress dhfr promoter activity, and that the E2F element modulates the activity of Sp1 at the dhfr promoter through a cis-acting mechanism.

PMID: 12788094 [PubMed - indexed for MEDLINE]

 
 
 
name :
password :
  comment :
 
 
ÀÌÀü±Û ¸ñ·Ï »õ±Û¾²±â ÀÀ´ä±Û¾²±â ±Û¼öÁ¤Çϱ⠱ÛÁö¿ì±â ´ÙÀ½±Û



96 Metastatic pleural cancer in radionuclide angiocardiography. A pulmonary time-activity curve mimicki  2009.02.2743778
95 Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy  2009.02.2648923
94 Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol.  2009.02.2640721
93 d-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kin  2009.02.2636144
92 Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-  2009.02.2638890
91 Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.  2009.02.2645209
90 The effect of parental imprinting on the INS-IGF2 locus of Korean type I diabetic patients.  2009.02.2639777
89 Usefulness of lumbar AP spine DXA for measuring the percentage of perilumbar regional fat and predic  2009.02.2637732
88 Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes  2009.02.2643897
87 Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell prolifer  2009.02.2644941
86 Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia.  2009.02.2644838
85 Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and  2009.02.2640395
84 Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in  2009.02.2643273
83 Postprandial hypertriglyceridemia-induced endothelial dysfunction in healthy subjects is independent  2009.02.2643099
82 Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea  2009.02.2640551
81 Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-kappa B.  2009.02.2639801
Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter.  2009.02.2639085
79 Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by in  2009.02.2638863
78 Functional characterization of the human resistin promoter with adipocyte determination- and differe  2009.02.2641554
77 Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through di  2009.02.2641184
 1 [2][3][4][5]
¸ñ·Ï »õ±Û¾²±â